UCLA
biochemists and colleagues have answered an important question about
the structure of microcompartments — the mysterious molecular
machines that seem to be present in a wide variety of pathogens and
other bacteria.
In the Feb. 22 issue of the journal Science, the biochemists
report how the microcompartment structure closes in three dimensions,
forming a shell around the enzymes encased inside.
If scientists could prevent or disrupt the formation of these
microcompartments, they could probably render the bacteria harmless,
said research co-author Todd O. Yeates, UCLA professor of chemistry and
biochemistry and a member of the UCLA–Department of
Energy Institute of Genomics and Proteomics. They do not yet know
how to do this, but the current research may provide a
framework for targeting microcompartments.
Yeates and his colleagues have identified the proteins that play
the critical role in how the structure folds in the carboxysome, a
protein shell that is the best-known and most-studied
microcompartment. The shell has a structure like a soccer ball or the
large, iconic dome structure at the Walt Disney World's Epcot Center.
"A soccer ball has hexagons and 12 pentagons at the corners; the
pentagons are essential to close the structure," said Yeates, who is
also a member of the California NanoSystems Institute at UCLA and
UCLA's Molecular Biology Institute. "The Epcot Center at Walt Disney
World has Spaceship Earth, a well-known dome structure composed of
triangles that fit into hexagons, but on closer inspection you will
find 12 locations where only five triangles come together; the same is
true of the Buckminster Fuller-type domes in the desert and many viral
structures.
"This principle of closing a structure by combining a large number
of hexagons with a small number of pentagons to create a piece of
curvature has been understood by architects, molecular biologists
studying viruses and soccer ball manufacturers."
That principle is also understood by microcompartments, in which
proteins form 12 pentagons to close the structure; fewer than 12 would
not completely close it, said Yeates, who calls the proteins
"pentameric carboxysome shell proteins."
The structure of the carboxysome shows a repeating pattern of six
protein molecules packed closely together. The carboxysome has more
than 3,000 sub-units with six edges and six vertices in a single shell,
Yeates said.
In August 2005, Yeates and colleagues reported in the journal
Science an underlying principle that governs the assembly of
microcompartments: The proteins that form the outer shell form
hexagons, which fit together to form extended two-dimensional molecular
sheets. The researchers hypothesized that the molecular
sheets formed by these hexagons formed the outer shell of the
microcompartment and the tiny holes allowed small molecules to move in
and out. Yeates and his colleagues have now answered how the shell
closes in three dimensions.
Yeates is now studying other microcompartments that are of
biomedical importance. Bacteria produce microcompartments when they
infect a host, he said.
"We're learning about the kinds of strategies that bacteria have
evolved to optimize the efficiency with which they operate or to deal
with challenges they face," Yeates said. "In some cases,
microcompartments are believed to serve a protective function,
protecting the cell."
In the future, Yeates wants to learn how the shell comes to
surround the enzymes, how microcompartments are formed and how
microcompartments differ from one another. He is also interested in
whether it is possible to create "designer microcompartments" that
would encase other enzymes.
A key distinction separating the cells of primitive organisms like
bacteria, known as prokaryotes, from the cells of complex organisms
like humans is that complex, or eukaryotic, cells have a much higher level of sub-cellular organization.
Yeates' research blurs the distinction between eukaryotic cells
and those of prokaryotes by showing that bacterial cells are more
complex than scientists had imagined.
If microcompartments can be engineered, biotechnology applications could potentially arise from this research, Yeates said.
The research was federally funded by the U.S. Department of Energy.
Co-authors are Shiho Tanaka, a UCLA graduate student of
biochemistry in Yeates' laboratory; Cheryl Kerfeld of the Joint
Genome Institute; Michael Sawaya, a research scientist with UCLA and
the Howard Hughes Medical Institute; and professors Gordon Cannon and
Sabine Heinhorst and graduate student Fei Cai of the University of
Southern Mississippi's department of chemistry and biochemistry.
UCLA is California's largest university, with an enrollment
of nearly 37,000 undergraduate and graduate students. The UCLA College
of Letters and Science and the university's 11 professional schools
feature renowned faculty and offer more than 300 degree programs and
majors. UCLA is a national and international leader in the breadth and
quality of its academic, research, health care, cultural, continuing
education and athletic programs. Four alumni and five faculty have been
awarded the Nobel Prize.


